XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 29, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income $ 159,552 $ 165,743
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization, and other impairment charges 57,090 48,699
Stock-based compensation expense 11,150 9,532
Deferred income tax 756 (4,725)
Non-cash interest expense 896 1,673
Pension settlement gain 0 (3,300)
Changes in operating assets and liabilities:    
Trade receivables, net (15,170) (7,361)
Inventories, net (16,212) (54,757)
Accounts payable (17,746) (10,916)
Other operating assets and liabilities 27,783 (21,673)
Net cash provided by operating activities 208,099 122,915
Cash flows from investing activities:    
Purchases of property, plant and equipment (28,865) (21,996)
Proceeds from sale of property, plant and equipment 5,171 4,322
Acquisition, net of cash received (18,665) 0
Net cash used in investing activities (42,359) (17,674)
Cash flows from financing activities:    
Proceeds from borrowings on term credit facility 0 1,000,000
Proceeds from borrowings on term credit facility 454,671 495,881
Repayments of borrowings on term credit facility (6,250) 0
Repayments of borrowings on revolving credit facility and other (578,623) (360,000)
Payment of deferred financing fees and other 0 (4,904)
Payment of deferred consideration 0 (1,500)
Payment of dividends (9,702) (3,025)
Consideration to Former Parent in connection with the Separation 0 (1,200,000)
Distributions to noncontrolling interest holders (2,279) (1,960)
Transfers from Former Parent, net 0 2,847
Net cash used in financing activities (142,183) (72,661)
Effect of foreign exchange rates on Cash and cash equivalents (12,748) (13,155)
Increase in Cash and cash equivalents 10,809 19,425
Cash and cash equivalents, beginning of period 72,024 41,209
Cash and cash equivalents, end of period $ 82,833 $ 60,634